Literature DB >> 8179376

Aortic valve replacement: determinants of operative mortality.

G W He1, T E Acuff, W H Ryan, M B Douthit, R T Bowman, Y H He, M J Mack.   

Abstract

Contradictory results have been reported regarding risk factors for aortic valve replacement (AVR). This study was designed to investigate determinants of operative mortality for AVR with emphasis on concomitant coronary artery bypass grafting (CABG) and old age. Between January 1986 and June 1992, 371 patients with a mean age of 61.99 +/- 0.76 years underwent AVR. There were 256 men (69.0%) and 115 women (31.0%). Twenty-six patients (7.0%) were 80 years old or older, and 97 (26.1%) were between 70 and 80 years old. Of these patients, 210 (56.6%) had isolated AVR, 142 (38.3%) had concomitant CABG, and 31 (8.4%) had concomitant mitral valve operations. Twenty patients (5.4%) underwent emergency operation. There were 33 operative deaths (8.9%). Univariate analysis and stepwise multiple logistic regression analysis were used to determine the risk factors for operative mortality. In the univariate analysis, 13 preoperative variables (sex, age, history of congestive heart failure, myocardial infarction, arrhythmia, functional class, class I/II versus III/IV, four variables related to aortic valve pathology, ejection fraction, left ventricular function) and 20 perioperative variables (emergency operation, individual surgeon, myocardial protection by type and route of cardioplegia, type of prosthesis, size of prosthesis, mean size by survival, small versus large size, concomitant procedure, concomitant CABG (versus others or AVR alone), concomitant mitral valve operation (versus others or AVR alone), concomitant CABG and MV operation, aortic cross-clamp time, cardiopulmonary bypass time, use and time of insertion of intraaortic balloon pump, low cardiac output, postoperative complications) were examined.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8179376     DOI: 10.1016/0003-4975(94)91344-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: comparison of characteristics and early outcome in the German multicenter TAVI registry.

Authors:  Mohamed Abdel-Wahab; Ralf Zahn; Martin Horack; Ulrich Gerckens; Gerhard Schuler; Horst Sievert; Christoph Naber; Matthias Voehringer; Ulrich Schäfer; Jochen Senges; Gert Richardt
Journal:  Clin Res Cardiol       Date:  2012-07-07       Impact factor: 5.460

2.  Survival after Aortic Valve Replacement for Aortic Regurgitation: Prediction from Preoperative Contractility Measurement.

Authors:  Jeffrey S Borer; Phyllis G Supino; Edmund McM Herrold; Antony Innasimuthu; Clare Hochreiter; Karl Krieger; Leonard N Girardi; O Wayne Isom
Journal:  Cardiology       Date:  2018-08-23       Impact factor: 1.869

3.  [Risk of perioperative mortality and complications following biological aortic valve replacement in elderly patients: stented vs unstented bioprotheses].

Authors:  J Ennker; I Florath; U Rosendahl; S Bauer; E von Hodenberg; I C Ennker
Journal:  Z Kardiol       Date:  2001-12

4.  Aortic valve replacement in the elderly. Risk factors and long-term results.

Authors:  E E Tseng; C A Lee; D E Cameron; R S Stuart; P S Greene; M S Sussman; L Watkins; T J Gardner; W A Baumgartner
Journal:  Ann Surg       Date:  1997-06       Impact factor: 12.969

5.  Identification of altered plasma proteins by proteomic study in valvular heart diseases and the potential clinical significance.

Authors:  Ge Gao; Chao Xuan; Qin Yang; Xiao-Cheng Liu; Zhi-Gang Liu; Guo-Wei He
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

6.  The top 100 manuscripts in emergency cardiac surgery. Potential role in cardiothoracic training. A bibliometric analysis.

Authors:  Rickesh B Karsan; Arfon Gmt Powell; Prakash Nanjaiah; Dheeraj Mehta; Vasileious Valtzoglou
Journal:  Ann Med Surg (Lond)       Date:  2019-05-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.